Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Candesartan in Diastolic Heart Failure with Diabetes and Hypertension
NCT00775840Phase 3Completed
- Sponsor
- Takeda
- Start
- Jan 2008
- Primary completion
- Dec 2008
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of candesartan in heart failure with preserved ejection fraction (HFpEF), sponsored by Takeda. Started Jan 2008; status: completed.
02
Drugs
candesartan
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT00775840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00775840.